Brain cancer gene therapy trial pulled before starting
NCT ID NCT04105374
First seen May 16, 2026 · Last updated May 16, 2026
Summary
This trial aimed to test whether adding a gene therapy (Toca 511) and a special pill (Toca FC) to standard radiation and chemotherapy could help people with a newly diagnosed aggressive brain cancer called glioblastoma. The treatment was designed to turn cancer cells into drug factories that kill themselves. However, the study was withdrawn before enrolling any participants, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANAPLASTIC ASTROCYTOMA are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.